Skip to content

A Comparison of Volumetric Laser Endomicroscopy (VLE) and Endoscopic Mucosal Resection (EMR) in Patients with Barrett*s Dysplasia or Intramucosal Adenocarcinoma

A Comparison of Volumetric Laser Endomicroscopy (VLE) and Endoscopic Mucosal Resection (EMR) in Patients with Barrett*s Dysplasia or Intramucosal Adenocarcinoma - nVision EMR

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON40469
Enrollment
50
Registered
2013-03-18
Start date
2013-05-13
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

1) Barrett's oesophagus 2) early oesophageal cancer

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Males and females over the age of 18 years. - Patients with either suspected or confirmed Barrett*s-associated dysplasia or intramucosal adenocarcinoma presenting for endoscopy likely requiring EMR. - Patients with non-dysplastic Barrett*s oesophagus - Eligible for endoscopic resection of Barrett mucosa. - Ability to provide written, informed consent.

Exclusion criteria

Exclusion criteria: - patients with a condition precluding full distension of the N-Vision balloon, such as strictures or a mass - inability to obtain biopsies and/or EMR (e.g. due to antocoagulation therapie, coagulation disorder, varices) - eosophillic oesophagitis - oesophagitis > LA grade A - pregnancy - unable to provide signed informed consent.

Design outcomes

Primary

MeasureTime frame
The primary endpoint will be the correlation of features seen on VLE images to those seen on histopathology from mucosal resection specimens.

Secondary

MeasureTime frame
The secondary endpoint will be the following: The creation of an image atlas, which will be used to determine the intra and inter observer agreement on VLE images in correlation with histopathology, resulting in refinement of the existing VLE image interpretation criteria and the validation of the VLE classification.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)